Durgam Suresh K. — SEC insider filings

SEC reporting owner CIK 1829958. 26 insider filings on record with FilingPulse; latest filed 2026-11-02.

Transaction summary — filings shown

Covers all 26 filings on record, filed 2021-01-12 to 2026-11-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Intra-Cellular Therapies, Inc. (ITCI)EVP, Chief Medical Officer25—37 legs · 165,885 sh · $10,053,21955
Helus Pharma Inc. (HELP)Director1———

Insider filings — Durgam Suresh K.

FiledFormIssuerReported transactionsSource
2026-11-023Helus Pharma Inc. (HELP)Holdings only — no transactions reportedEDGAR
2025-04-024Intra-Cellular Therapies, Inc. (ITCI)Disposition to issuer (D): 42,913 @ $132 · Disposition to issuer (D): 53,967 (derivative) · Disposition to issuer (D): 33,443 (derivative) · Disposition to issuer (D): 18,714 (derivative) · Disposition to issuer (D): 17,916 (derivative) · Disposition to issuer (D): 13,133 (derivative) · +6 moreEDGAR
2025-03-104Intra-Cellular Therapies, Inc. (ITCI)Option exercise (M): 13,133 · Tax withholding (F): 5,572 @ $131.19 · Option exercise (M): 7,345 · Tax withholding (F): 3,116 @ $131.24 · Option exercise (M): 13,133 (derivative) @ $0 · Option exercise (M): 7,345 (derivative) @ $0EDGAR
2025-03-044Intra-Cellular Therapies, Inc. (ITCI)Option exercise (M): 8,742 · Tax withholding (F): 3,709 @ $128.20 · Option exercise (M): 8,742 (derivative) @ $0EDGAR
2025-02-044Intra-Cellular Therapies, Inc. (ITCI)Grant/award (A): 11,017 @ $0 · Tax withholding (F): 4,730 @ $127 · Grant/award (A): 24,621 (derivative) @ $0EDGAR
2024-03-114Intra-Cellular Therapies, Inc. (ITCI)Sale (S): 3,728 @ $66.34 · Sale (S): 2,722 @ $66.86 · Option exercise (M): 7,345 · Sale (S): 2,179 @ $65.06 · Sale (S): 872 @ $65.89 · Sale (S): 661 @ $66.96 · +1 moreEDGAR
2024-03-084Intra-Cellular Therapies, Inc. (ITCI)Option exercise (M): 13,132 · Option exercise (M): 13,132 (derivative) @ $0EDGAR
2024-03-054Intra-Cellular Therapies, Inc. (ITCI)Grant/award (A): 26,227 (derivative) @ $0EDGAR
2024-02-274Intra-Cellular Therapies, Inc. (ITCI)Option exercise (M): 7,907 · Sale (S): 1,400 @ $69.38 · Sale (S): 1,400 @ $70.16 · Sale (S): 1,312 @ $71.02 · Option exercise (M): 7,907 (derivative) @ $0EDGAR
2024-02-054Intra-Cellular Therapies, Inc. (ITCI)Grant/award (A): 11,860 @ $0 · Sale (S): 2,320 @ $66.69 · Sale (S): 3,847 @ $67.49EDGAR
2024-01-044Intra-Cellular Therapies, Inc. (ITCI)Option exercise (M): 62,282 @ $19.87 · Sale (S): 37,427 @ $70.41 · Sale (S): 22,645 @ $70.80 · Sale (S): 2,210 @ $71.77 · Option exercise (M): 62,282 (derivative) @ $0EDGAR
2023-12-154Intra-Cellular Therapies, Inc. (ITCI)Sale (S): 21,262 @ $65EDGAR
2023-07-204Intra-Cellular Therapies, Inc. (ITCI)Sale (S): 1,842 @ $65EDGAR
2023-03-134Intra-Cellular Therapies, Inc. (ITCI)Option exercise (M): 7,344 · Sale (S): 6,998 @ $45.08 · Sale (S): 346 @ $44.29 · Option exercise (M): 7,344 (derivative) @ $0EDGAR
2023-03-084Intra-Cellular Therapies, Inc. (ITCI)Grant/award (A): 39,398 (derivative) @ $0EDGAR
2023-02-274Intra-Cellular Therapies, Inc. (ITCI)Option exercise (M): 7,906 · Sale (S): 7,906 @ $47.14 · Option exercise (M): 7,906 (derivative) @ $0EDGAR
2023-02-224Intra-Cellular Therapies, Inc. (ITCI)Option exercise (M): 8,354 · Sale (S): 6,673 @ $46.55 · Sale (S): 800 @ $47.20 · Sale (S): 806 @ $48.63 · Sale (S): 75 @ $49.60 · Option exercise (M): 8,354 (derivative) @ $0EDGAR
2022-03-144Intra-Cellular Therapies, Inc. (ITCI)Grant/award (A): 17,916 (derivative) @ $0 · Grant/award (A): 22,034 (derivative) @ $0EDGAR
2022-03-044Intra-Cellular Therapies, Inc. (ITCI)Sale (S): 4,177 @ $56.98 · Sale (S): 3,860 @ $55.52EDGAR
2022-02-254Intra-Cellular Therapies, Inc. (ITCI)Option exercise (M): 7,906 · Sale (S): 1,203 @ $53.04 · Sale (S): 2,162 @ $52.13 · Sale (S): 681 @ $51.33 · Option exercise (M): 7,906 (derivative) @ $0EDGAR
2022-02-234Intra-Cellular Therapies, Inc. (ITCI)Option exercise (M): 8,354 · Sale (S): 2,820 @ $55.53 · Sale (S): 1,357 @ $54.80 · Option exercise (M): 8,354 (derivative) @ $0EDGAR
2022-01-204Intra-Cellular Therapies, Inc. (ITCI)Sale (S): 6,223 @ $42.03EDGAR
2022-01-114Intra-Cellular Therapies, Inc. (ITCI)Option exercise (M): 13,093 · Sale (S): 1,520 @ $41.48 · Sale (S): 4,850 @ $40.63 · Sale (S): 500 @ $39.83 · Option exercise (M): 13,093 (derivative) @ $0EDGAR
2021-02-254Intra-Cellular Therapies, Inc. (ITCI)Grant/award (A): 18,714 (derivative) @ $0 · Grant/award (A): 23,719 (derivative) @ $0EDGAR
2021-02-224Intra-Cellular Therapies, Inc. (ITCI)Option exercise (M): 8,354 · Sale (S): 2,534 @ $39.28 · Sale (S): 200 @ $38.87 · Option exercise (M): 8,354 (derivative) @ $0EDGAR
2021-01-124Intra-Cellular Therapies, Inc. (ITCI)Option exercise (M): 13,092 · Sale (S): 4,267 @ $32.13 · Sale (S): 100 @ $31.60 · Option exercise (M): 13,092 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-01-06 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1829958 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs